Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Shahed Nicolas Badiyan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6243-526X; OpenAlex author ID A5068905445. Sources: ClinicalTrials.gov.

Their work

Papers
10 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper, 1 trial · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. Post-operative patterns of failure and outcomes reveal opportunities to optimize treatment of recurrent pancreatic cancer Co-author DOI 10.1101/2025.11.08.25339815↗
  2. Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally … Co-author DOI 10.1016/j.radonc.2024.110473↗
  3. MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial. Co-author DOI 10.1016/j.ijrobp.2022.07.015↗
  4. Knowledge-based adaptive planning quality assurance using dosimetric indicators for stereotactic adaptive radiotherapy for pancreatic cancer. Co-author DOI 10.1016/j.radonc.2023.109603↗
  5. High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival. Co-author DOI 10.1038/s41698-023-00455-z↗
  6. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Co-author DOI 10.1016/j.radonc.2022.08.026↗
  7. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR). Co-author DOI 10.1186/s13014-022-02125-z↗
  8. Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer. First author DOI 10.21037/jgo.2018.03.14↗
  9. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings. Co-author DOI 10.1016/j.soc.2017.01.012↗
  10. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pa… Co-author DOI 10.1097/coc.0000000000000003↗

Trials 1

  1. Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) Principal investigator NCT02885727↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hyun Jee Kim · 6 shared papers, 2022–2024 · strength 0.91
  2. Lauren E. Henke · 5 shared papers, 2022–2024 · strength 0.78
  3. Joshua P. Schiff · 4 shared papers, 2022–2024 · strength 0.64
  4. Clifford Grant Robinson · 3 shared papers, 2022–2024 · strength 0.48
  5. Alex T. Price · 3 shared papers, 2022–2023 · strength 0.46
  6. William G. Hawkins · 3 shared papers, 2016–2023 · strength 0.31
  7. Kian‐Huat Lim · 2 shared papers, 2023 · strength 0.26
  8. Ryan C Fields · 2 shared papers, 2023 · strength 0.26
  9. John Michael P. Tomagan · 1 shared paper, 2025 · strength 0.23
  10. Nina Niu Sanford · 1 shared paper, 2025 · strength 0.23
  11. Patricio Marcelo Polanco · 1 shared paper, 2025 · strength 0.23
  12. Ahmed M. Elamir · 1 shared paper, 2025 · strength 0.23
  13. Syed Mohammad Ali Kazmi · 1 shared paper, 2025 · strength 0.23
  14. Todd Anthony Aguilera · 1 shared paper, 2025 · strength 0.23
  15. Peter Q. Leung · 1 shared paper, 2025 · strength 0.23
  16. Matthew R. Porembka · 1 shared paper, 2025 · strength 0.23
  17. Salwan S. Al Mutar · 1 shared paper, 2025 · strength 0.23
  18. Herbert J. Zeh · 1 shared paper, 2025 · strength 0.23
  19. Parag Jitendra Parikh · 2 shared papers, 2016–2023 · strength 0.19
  20. Andrea Wang‐Gillam · 2 shared papers, 2016–2023 · strength 0.19
  21. Alden D'Souza · 1 shared paper, 2024 · strength 0.18
  22. Minsol Kim · 1 shared paper, 2022 · strength 0.16
  23. William F. Regine · 2 shared papers, 2017–2018 · strength 0.16
  24. Michael David Chuong · 2 shared papers, 2017–2018 · strength 0.16
  25. Farnoush Forghani · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.